DK62184D0 - Diffusionsovertrukket polydepotpraeparat - Google Patents

Diffusionsovertrukket polydepotpraeparat

Info

Publication number
DK62184D0
DK62184D0 DK0621/84A DK62184A DK62184D0 DK 62184 D0 DK62184 D0 DK 62184D0 DK 0621/84 A DK0621/84 A DK 0621/84A DK 62184 A DK62184 A DK 62184A DK 62184 D0 DK62184 D0 DK 62184D0
Authority
DK
Denmark
Prior art keywords
polydepot
preparation
diffusion coated
diffusion
coated
Prior art date
Application number
DK0621/84A
Other languages
Danish (da)
English (en)
Inventor
Kim Kjoernaes
Joergen Linnemann
Original Assignee
Benzon As Alfred
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benzon As Alfred filed Critical Benzon As Alfred
Priority to DK0621/84A priority Critical patent/DK62184D0/da
Publication of DK62184D0 publication Critical patent/DK62184D0/da
Priority to AU39358/85A priority patent/AU570540B2/en
Priority to PCT/DK1985/000006 priority patent/WO1985003437A1/fr
Priority to JP60500758A priority patent/JPH0759500B2/ja
Priority to DE8585300844T priority patent/DE3587274T2/de
Priority to JP60500757A priority patent/JPH0759499B2/ja
Priority to EP85300845A priority patent/EP0153105B1/fr
Priority to EP85300844A priority patent/EP0153104B1/fr
Priority to US06/795,497 priority patent/US4716041A/en
Priority to US06/786,967 priority patent/US4713248A/en
Priority to PCT/DK1985/000005 priority patent/WO1985003436A1/fr
Priority to IE30785A priority patent/IE59287B1/en
Priority to DE8585300845T priority patent/DE3586600T2/de
Priority to AU39359/85A priority patent/AU571312B2/en
Priority to IE30885A priority patent/IE59797B1/en
Priority to CA000474047A priority patent/CA1248023A/fr
Priority to CA000474048A priority patent/CA1247009A/fr
Priority to NO853955A priority patent/NO173316C/no
Priority to DK462585A priority patent/DK158562C/da
Priority to FI853934A priority patent/FI85439C/fi
Priority to DK462685A priority patent/DK158032C/da
Priority to HK97101752.0A priority patent/HK1000201B/en
Priority to HK98100527.5A priority patent/HK1001554B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK0621/84A 1984-02-10 1984-02-10 Diffusionsovertrukket polydepotpraeparat DK62184D0 (da)

Priority Applications (23)

Application Number Priority Date Filing Date Title
DK0621/84A DK62184D0 (da) 1984-02-10 1984-02-10 Diffusionsovertrukket polydepotpraeparat
IE30885A IE59797B1 (en) 1984-02-10 1985-02-08 Diffusion coated multiple-units dosage form
PCT/DK1985/000005 WO1985003436A1 (fr) 1984-02-10 1985-02-08 Formulation de dosage d'unites multiples enrobees a liberation par diffusion
DE8585300845T DE3586600T2 (de) 1984-02-10 1985-02-08 Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend.
JP60500758A JPH0759500B2 (ja) 1984-02-10 1985-02-08 拡散被覆された複合単位服用剤
DE8585300844T DE3587274T2 (de) 1984-02-10 1985-02-08 Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend.
JP60500757A JPH0759499B2 (ja) 1984-02-10 1985-02-08 拡散被覆された複合単位服用剤
EP85300845A EP0153105B1 (fr) 1984-02-10 1985-02-08 Dose à base d'unités multiples enrobées par une couche de diffusion
EP85300844A EP0153104B1 (fr) 1984-02-10 1985-02-08 Dose à base d'unités multiples enrobées par une couche de diffusion
US06/795,497 US4716041A (en) 1984-02-10 1985-02-08 Diffusion coated multiple-units dosage form
US06/786,967 US4713248A (en) 1984-02-10 1985-02-08 Diffusion coated multiple-units dosage form
AU39358/85A AU570540B2 (en) 1984-02-10 1985-02-08 Diffusion coated multiple-units dosage form
IE30785A IE59287B1 (en) 1984-02-10 1985-02-08 Diffusion coated multiple-units dosage form
PCT/DK1985/000006 WO1985003437A1 (fr) 1984-02-10 1985-02-08 Formulation de dosage d'unites multiples enrobees a liberation par diffusion
AU39359/85A AU571312B2 (en) 1984-02-10 1985-02-08 Diffusion coated multiple-units dosage form
CA000474048A CA1247009A (fr) 1984-02-10 1985-02-11 Forme posologique a unites multiples a enrobage diffusible dans l'eau
CA000474047A CA1248023A (fr) 1984-02-10 1985-02-11 Forme posologique a unites multiples enrobees d'une matiere diffusible dans l'eau
NO853955A NO173316C (no) 1984-02-10 1985-10-07 Fremgamgsm}te til fremstilling av en oral farmas!ytisk flerenhetssammensetning med regulert utlevering
DK462585A DK158562C (da) 1984-02-10 1985-10-09 Diffusionsovertrukket polydepotpraeparat og fremgangsmaade til fremstilling deraf
FI853934A FI85439C (fi) 1984-02-10 1985-10-09 Foerfarande foer framstaellning av ett laekemedelspreparat som doseras oralt och moejliggoer en kontrollerad frigoerelse.
DK462685A DK158032C (da) 1984-02-10 1985-10-09 Polydepotpraeparat med kontrolleret afgivelse af aktivt stof og fremgangsmaade til fremstilling af dette polydepotpraeparat
HK97101752.0A HK1000201B (en) 1984-02-10 1997-09-09 Diffusion coated multiple-units dosage form
HK98100527.5A HK1001554B (en) 1984-02-10 1998-01-21 Diffusion coated multiple-units dosage form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK0621/84A DK62184D0 (da) 1984-02-10 1984-02-10 Diffusionsovertrukket polydepotpraeparat

Publications (1)

Publication Number Publication Date
DK62184D0 true DK62184D0 (da) 1984-02-10

Family

ID=8095649

Family Applications (2)

Application Number Title Priority Date Filing Date
DK0621/84A DK62184D0 (da) 1984-02-10 1984-02-10 Diffusionsovertrukket polydepotpraeparat
DK462585A DK158562C (da) 1984-02-10 1985-10-09 Diffusionsovertrukket polydepotpraeparat og fremgangsmaade til fremstilling deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK462585A DK158562C (da) 1984-02-10 1985-10-09 Diffusionsovertrukket polydepotpraeparat og fremgangsmaade til fremstilling deraf

Country Status (11)

Country Link
US (1) US4713248A (fr)
EP (1) EP0153104B1 (fr)
JP (1) JPH0759500B2 (fr)
AU (1) AU570540B2 (fr)
CA (1) CA1248023A (fr)
DE (1) DE3587274T2 (fr)
DK (2) DK62184D0 (fr)
FI (1) FI85439C (fr)
IE (1) IE59797B1 (fr)
NO (1) NO173316C (fr)
WO (1) WO1985003437A1 (fr)

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
IE59287B1 (en) * 1984-02-10 1994-02-09 Benzon Pharma As Diffusion coated multiple-units dosage form
US4568560A (en) * 1984-03-16 1986-02-04 Warner-Lambert Company Encapsulated fragrances and flavors and process therefor
DE3431861A1 (de) * 1984-08-30 1986-03-13 Troponwerke GmbH & Co KG, 5000 Köln Pellet-zubereitung
LU85943A1 (fr) * 1985-06-12 1987-01-13 Galephar Comprimes pharmaceutiques permettant l'administration aisee de pellets, leur preparation et leur utilisation
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
EP0212746B1 (fr) * 1985-08-16 1991-04-10 The Procter & Gamble Company Particules pour une libération constante de la substance active
DE3678641D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Partikel mit konstanter wirkstofffreisetzung.
EP0212747B1 (fr) * 1985-08-16 1991-04-10 The Procter & Gamble Company Particules d'une substance active à libération constante et immédiate
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
LU86077A1 (fr) * 1985-09-18 1987-04-02 Pharlyse Sa Nouvelles formes galeniques du verapamil,leur fabrication et medicaments contenant ces nouvelles formes galeniques
LU86099A1 (fr) * 1985-09-30 1987-04-02 Pharlyse Formes galeniques a liberation prolongee du verapamil,leur fabrication et medicaments les contenant
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
US4826688A (en) * 1985-11-13 1989-05-02 501 Elan Corporation PLC. Controlled absorption pharmaceutical formulation
CH669523A5 (fr) * 1986-06-25 1989-03-31 Mepha Ag
USD301762S (en) 1986-07-14 1989-06-20 Euroceltique S.A. Tablet
US4710384A (en) * 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
US4752470A (en) * 1986-11-24 1988-06-21 Mehta Atul M Controlled release indomethacin
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
US4820524A (en) * 1987-02-20 1989-04-11 Mcneilab, Inc. Gelatin coated caplets and process for making same
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US4832955A (en) * 1988-02-26 1989-05-23 Zetachron, Inc. Controlled release potassium chloride composition
AU618096B2 (en) * 1988-04-19 1991-12-12 Southwest Research Institute Controlled release of active ingredients from capsules having a salt sensitive shell material
US5064650A (en) * 1988-04-19 1991-11-12 Southwest Research Institute Controlled-release salt sensitive capsule for oral use and adhesive system
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
USD309035S (en) 1989-03-30 1990-07-03 The Upjohn Company Drug tablet
USD315223S (en) 1989-05-03 1991-03-05 Warner-Lambert Company Tablet
DK161743C (da) * 1989-07-03 1992-02-17 Niro Atomizer As Fremgangsmaade og apparat til agglomerering af et pulverformigt materiale
USD335704S (en) 1990-03-27 1993-05-18 Olin Corporation Partially shell encased swimming pool chemical tablet
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
GB9025372D0 (en) * 1990-11-22 1991-01-09 Nat Res Dev Pharmaceutical dosage forms
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5256440A (en) * 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5422122A (en) * 1992-08-04 1995-06-06 Eurand America, Incorporated Controlled release potassium chloride tablet
KR100209818B1 (ko) * 1992-09-04 1999-07-15 사또 아끼오 분해성점착필름 및 분해성수지조성물
DE4333190C2 (de) * 1993-09-29 1996-05-30 Korsatko Werner Univ Prof Dr E Zerbeißtablette mit verzögerter Wirkstoff-Freisetzung
FR2717388B1 (fr) * 1994-03-21 1996-11-22 Synthelabo Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine.
IT1270239B (it) * 1994-06-17 1997-04-29 Zambon Spa Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
US5744164A (en) * 1994-12-16 1998-04-28 Nestec S.A. Sustained release microparticulate caffeine formulation
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
US5683718A (en) * 1995-04-04 1997-11-04 Time-Cap Labs, Inc. Enteric coated tablet with raised identification character and method of manufacture
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
US6123797A (en) * 1995-06-23 2000-09-26 The Dow Chemical Company Method for coating a non-wetting fluidizable and material onto a substrate
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US8524277B2 (en) * 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
DE19820529A1 (de) 1998-05-08 1999-11-11 Lohmann Therapie Syst Lts Wirkstoff enthaltende orale und mucosale Zubereitung mit steuerbarer Wirkstofffreisetzung und ihre Verwendung
US6602521B1 (en) * 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
JP2002535353A (ja) 1999-01-29 2002-10-22 ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク 医薬品組成物
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6274162B1 (en) 2000-01-14 2001-08-14 Bpsi Holdings, Inc. Elegant film coating system
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
USD440650S1 (en) 2000-01-27 2001-04-17 Watson Pharmaceuticals, Inc. Tablet
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
IT1318625B1 (it) * 2000-07-14 2003-08-27 Roberto Valducci Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
US6699315B2 (en) 2000-11-28 2004-03-02 Fmc Corporation Edible PGA coating composition
KR20040047747A (ko) 2001-03-13 2004-06-05 펜웨스트 파머슈티칼즈 컴파니 변시치료 제형
ATE508725T1 (de) * 2001-06-20 2011-05-15 Takeda Pharmaceutical Verfahren zur herstellung von tabletten
AR034813A1 (es) † 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
JP4848101B2 (ja) * 2001-08-17 2011-12-28 株式会社フジモト・コーポレーション 徐放性マイクロペレット
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
MXPA04006163A (es) * 2001-12-20 2004-11-01 Pharmacia Corp Formas de dosis de liberacion sostenida del orden-cero y metodo de fabricacion de las mismas.
WO2003103637A2 (fr) * 2002-01-10 2003-12-18 Ranbaxy Laboratories Limited Systemes d'administration de medicaments a unites multiples et a liberation modifiee
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
WO2004075841A2 (fr) * 2003-02-24 2004-09-10 Mallinckrodt Inc. Procede ameliore pour la preparation de benzhydrylthioacetamide
WO2004112756A1 (fr) 2003-06-26 2004-12-29 Isa Odidi Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif
US7632521B2 (en) 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
CN1819821B (zh) 2003-08-08 2010-10-13 拜奥维尔实验室国际股份有限公司 盐酸安非他酮的改良释放片剂
EA200600598A1 (ru) 2003-09-19 2006-08-25 Пенвест Фармасьютикалз Ко. Лекарственные формы замедленного высвобождения
US7387793B2 (en) * 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
USD500849S1 (en) * 2004-01-13 2005-01-11 Roger A. Rinker Medicinal tablet
USD525356S1 (en) * 2004-01-13 2006-07-18 Rinker Roger A Medicinal tablet
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
USD515202S1 (en) * 2004-07-19 2006-02-14 Merck & Co., Inc Tablet
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
WO2006047493A2 (fr) 2004-10-21 2006-05-04 Eurand Pharmaceuticals Limited Compositions pharmaceutiques a saveur masquee avec substances porogenes gastrosolubles
CA2592605C (fr) 2004-12-27 2010-12-07 Eisai R&D Management Co., Ltd. Methode de stabilisation d'un medicament contre la demence
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
USD564086S1 (en) * 2005-05-30 2008-03-11 Nycomed Pharma A/S Tablet
KR100831771B1 (ko) 2005-10-27 2008-05-27 주식회사종근당 서방출과 ｐＨ 의존성 속방출을 나타내는 약제학적 조성물
BRPI0520797B8 (pt) * 2005-11-18 2021-05-25 Accu Break Tech Inc forma de dosagem farmacêutica comprimida em bicamadas
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
USD534646S1 (en) * 2006-01-06 2007-01-02 Access Business Group International Llc Nutritional supplement tablet
CN104825397A (zh) 2006-04-03 2015-08-12 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
KR101422052B1 (ko) * 2006-04-19 2014-07-23 아지노모토 가부시키가이샤 할선 정제
JP5320759B2 (ja) * 2006-04-19 2013-10-23 味の素株式会社 割線錠剤
WO2007122478A2 (fr) * 2006-04-20 2007-11-01 Themis Laboratories Private Limited Compositions à unités multiples
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
JP2009541337A (ja) * 2006-06-19 2009-11-26 マクニール−ピーピーシー・インコーポレーテツド 活性成分を含有する腸溶性の被覆された粒子
KR100812538B1 (ko) 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
US20080131467A1 (en) * 2006-11-30 2008-06-05 Dennis Nelson Film-coated solid dosage form
USD592313S1 (en) * 2007-07-12 2009-05-12 Anthony Harris Levine Massager
US20100136110A1 (en) * 2008-09-30 2010-06-03 Astellas Pharma Inc. Granular pharmaceutical composition for oral administration
USD631537S1 (en) 2009-09-15 2011-01-25 Mcneil-Ppc, Inc. Oral dosage form
SG10201407965XA (en) 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
TR201905378T4 (tr) * 2010-01-29 2019-05-21 Monosol Llc Pvoh polimerlerinin harmanına sahip geliştirilmiş suda çözünür film ve bundan üretilen paketler.
US7992713B1 (en) * 2010-12-28 2011-08-09 Emc Corporation Disk drive package
USD755949S1 (en) * 2013-07-30 2016-05-10 Reckitt Benckiser Llc Tablet
USD741990S1 (en) 2013-07-30 2015-10-27 Reckitt Benckiser Llc Tablet
USD907235S1 (en) * 2017-09-18 2021-01-05 University Of Hertfordshire Higher Education Corporation Enclosure for dissolution system
USD1057201S1 (en) * 2022-08-03 2025-01-07 Joseph Joseph Ltd. Combined pestle and mortar lid
USD1071139S1 (en) * 2023-03-13 2025-04-15 Kenvue Brands Llc Dosage form
CN117550553B (zh) * 2023-11-14 2026-04-28 西安一九零八新能源科技有限公司 一种金属氢化物复合材料的制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL235736A (fr) * 1958-02-03
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
DE1204363B (de) * 1963-09-10 1965-11-04 Hoffmann La Roche Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt
FR1396710A (fr) * 1964-06-15 1965-04-23 Diwag Chemische Fabriken G M B Procédé pour la fabrication de charges ou supports perfectionnés et produits obtenus
FR1545612A (fr) * 1967-06-15 1968-11-15 Dausse Lab Procédé de fabrication de comprimés
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
US4178361A (en) * 1973-09-10 1979-12-11 Union Corporation Sustained release pharmaceutical composition
JPS5512411B2 (fr) * 1974-03-12 1980-04-02
JPS517116A (en) * 1974-06-11 1976-01-21 Shinetsu Chemical Co Choyoseihifukuyakuzaino seizohoho
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
JPS53139715A (en) * 1977-05-11 1978-12-06 Shin Etsu Chem Co Ltd Method of coating solid medicine
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
SE7813246L (sv) * 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US4259315A (en) * 1980-06-13 1981-03-31 A. H. Robins Company, Inc. Controlled release potassium dosage form
EP0052075A1 (fr) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Granule pharmaceutique à action retardée
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
IT1168014B (it) * 1981-08-05 1987-05-20 Erba Farmitalia Forme farmaceutiche a cessione protratta
JPS5867616A (ja) * 1981-10-15 1983-04-22 Tanabe Seiyaku Co Ltd 腸溶性マイクロカプセル
WO1984000004A1 (fr) * 1982-06-14 1984-01-05 Key Pharma Aspirine a liberation entretenue
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
SE8404467D0 (sv) * 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations

Also Published As

Publication number Publication date
EP0153104A3 (en) 1985-12-18
EP0153104B1 (fr) 1993-04-21
NO173316B (no) 1993-08-23
NO853955L (no) 1985-11-14
FI853934A0 (fi) 1985-10-09
HK1001554A1 (en) 1998-06-26
CA1248023A (fr) 1989-01-03
DK158562B (da) 1990-06-11
EP0153104A2 (fr) 1985-08-28
JPH0759500B2 (ja) 1995-06-28
FI85439C (fi) 1992-04-27
FI85439B (fi) 1992-01-15
NO173316C (no) 1993-12-01
DE3587274D1 (de) 1993-05-27
US4713248A (en) 1987-12-15
DK158562C (da) 1990-11-05
IE59797B1 (en) 1994-04-06
FI853934L (fi) 1985-10-09
IE850308L (en) 1985-08-10
DK462585D0 (da) 1985-10-09
JPS61501151A (ja) 1986-06-12
DK462585A (da) 1985-10-09
AU570540B2 (en) 1988-03-17
WO1985003437A1 (fr) 1985-08-15
DE3587274T2 (de) 1993-09-09
AU3935885A (en) 1985-08-27

Similar Documents

Publication Publication Date Title
DK462585D0 (da) Diffusionsovertrukket polydepotpraeparat
DK462685D0 (da) Diffusionsovertrukket polydepotpraeparat
IT1184597B (it) Rivestimento microlaminato
MX163672B (es) Revestimiento opalescente
DK312884A (da) Applicator
DE3687873D1 (de) Beschichtungszusammensetzung.
FR2571818B1 (fr) Raccord auto-obturateur
BR8506848A (pt) Revestimento anti-ofuscante
DK500185A (da) Oploeseliggjort platinforbindelse
DK548285A (da) Belaegningssammensaetning
DE3685948D1 (de) Ueberzugszusammensetzung.
FR2573843B1 (fr) Raccord
FI875230A0 (fi) Päällystyslaite
DK62084D0 (da) Diffusionsovertrukket polydepotpraeparat
KR850006361U (ko) 의 자
KR860006692U (ko) 소형 바리콘
KR860007208U (ko) 못자리용 의자
BR8405674A (pt) Revestimento
BR6401826U (pt) Revestimento
BR8405124A (pt) Cobertura compactavel
KR860000420U (ko) 과도
BR6402053U (pt) Encosto
SE8406400D0 (sv) Handeldvapen
SE8406403D0 (sv) Handeldvapen
SE8406402D0 (sv) Handeldvapen

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment